Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
Автор: ReachMD
Загружено: 2026-01-30
Просмотров: 15
Описание:
Host: Holly M. Brothers, PhD
Guest: Niklas Mattsson-Carlgren, MD, PhD
The prevalence of dementia is projected to almost double every 20 years.1 Alzheimer’s disease (AD) is the most common cause of dementia,2 making early diagnosis and management increasingly important. Based on our current understanding of its pathology, AD is an amyloid driven tauopathy3 with biomarker changes occurring years before clinical symptoms appear.4 Learn more with this webinar featuring Dr Niklas Mattsson-Carlgren, Associate Professor at Lund University as he explores the relationship between amyloid beta and tau, the correlation between pathology and clinical symptoms, and biomarker progression across the AD continuum. To learn more about tau in Alzheimer’s disease, explore the Know Tau medical education platform. Know Tau is created and funded by Biogen and is intended for healthcare professionals only. References: Alzheimer’s Disease International. Numbers of people with dementia worldwide. Available from: https://www.alzint.org/resource/numbe... (Accessed June 2025) Alzheimer’s Association. Alzheimer’s disease facts and figures. Available from: https://www.alz.org/alzheimers-dement... (Accessed June 2025) Aksman LM, et al. Brain 2023;146:4935–4948 Jack CR Jr, et al. Alzheimers Dement 2018;14:535–562
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
